BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14659465)

  • 1. IL-15 in the life and death of lymphocytes: immunotherapeutic implications.
    Waldmann TA
    Trends Mol Med; 2003 Dec; 9(12):517-21. PubMed ID: 14659465
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

  • 3. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.
    Waldmann TA
    Nat Rev Immunol; 2006 Aug; 6(8):595-601. PubMed ID: 16868550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of homeostasis of CD8+ memory T cells by opposing cytokines.
    Ku CC; Murakami M; Sakamoto A; Kappler J; Marrack P
    Science; 2000 Apr; 288(5466):675-8. PubMed ID: 10784451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-2/IL-15 receptor systems: targets for immunotherapy.
    Waldmann TA
    J Clin Immunol; 2002 Mar; 22(2):51-6. PubMed ID: 11998892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 and interleukin-15: immunotherapy for cancer.
    Fehniger TA; Cooper MA; Caligiuri MA
    Cytokine Growth Factor Rev; 2002 Apr; 13(2):169-83. PubMed ID: 11900992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-15 and the regulation of lymphoid homeostasis.
    Lodolce J; Burkett P; Koka R; Boone D; Chien M; Chan F; Madonia M; Chai S; Ma A
    Mol Immunol; 2002 Dec; 39(9):537-44. PubMed ID: 12431387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15/IL-15 receptor biology: a guided tour through an expanding universe.
    Budagian V; Bulanova E; Paus R; Bulfone-Paus S
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):259-80. PubMed ID: 16815076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 as immunotherapeutic in the autoimmune diseases.
    Orozco Valencia A; Camargo Knirsch M; Suavinho Ferro E; Antonio Stephano M
    Int Immunopharmacol; 2020 Apr; 81():106296. PubMed ID: 32058934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases.
    Waldmann TA
    Arthritis Res Ther; 2004; 6(4):174-7. PubMed ID: 15225362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and regulation of IL-2: from molecular mechanisms to human therapy.
    Spolski R; Li P; Leonard WJ
    Nat Rev Immunol; 2018 Oct; 18(10):648-659. PubMed ID: 30089912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of cytokines for maintenance of memory CD8+ T cells].
    Kamon H; Murakami M
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2313-7. PubMed ID: 12518454
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression.
    Schluns KS; Nowak EC; Cabrera-Hernandez A; Puddington L; Lefrançois L; Aguila HL
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5616-21. PubMed ID: 15060278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.
    Arenas-Ramirez N; Zou C; Popp S; Zingg D; Brannetti B; Wirth E; Calzascia T; Kovarik J; Sommer L; Zenke G; Woytschak J; Regnier CH; Katopodis A; Boyman O
    Sci Transl Med; 2016 Nov; 8(367):367ra166. PubMed ID: 27903862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth.
    Rao BM; Driver I; Lauffenburger DA; Wittrup KD
    Biochemistry; 2005 Aug; 44(31):10696-701. PubMed ID: 16060678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising immunotherapy technique.
    Fillon M
    J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin 15.
    Cosman D; Kumaki S; Anderson D; Kennedy M; Eisenman J; Park L
    Biochem Soc Trans; 1997 May; 25(2):371-4. PubMed ID: 9191120
    [No Abstract]   [Full Text] [Related]  

  • 18. Lowest dose interleukin-2 immunotherapy.
    Smith KA
    Blood; 1993 Mar; 81(6):1414-23. PubMed ID: 8453090
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin 2: a review.
    Kolitz JE; Welte K; Sykora KW; Mertelsmann R
    Arzneimittelforschung; 1985; 35(10):1607-15. PubMed ID: 3000391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine control of memory T-cell development and survival.
    Schluns KS; Lefrançois L
    Nat Rev Immunol; 2003 Apr; 3(4):269-79. PubMed ID: 12669018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.